Download DANISH BIOTECH COMPANIES YEAR OF ESTABLISHMENT TYPE

DANISH BIOTECH COMPANIES
YEAR OF
ESTABLISHMENT
Acadia Pharmaceuticals A/S
ACE Biosciences A/S
Action Pharma A/S
AgroFerm A/S
Alk-Abello A/S
Alkalon ApS
Alpharma ApS
Antibody project ApS
Eftertryk er tilladt med tydelig angivelse af kilde
1997
2000
TYPE OF
ACTIVITY
COMPANY FOCUS AREA
CONTACT INFORMATION
R&D
Drug discovery and clinical development of novel treatments for
schizophrenia, Parkinson's disease, and other central nervous
system disorders.
Acadia Pharmaceuticals A/S,
Bredgade 38, 1260 København K
Tel. +45 4329 3000
www.acadia-pharm.com
R&D
Develops novel, protein-based vaccines and antibodies to address
infectious diseases caused by pathogens such as bacteria, fungi
and viruses.
ACE BioSciences A/S,
Unsbjergvej 2a, 5220 Odense SØ,
Tel. +45 6565 2121
www.acebiosciences.com
2000
R&D
New drugs and treatment concepts within cardiovascular diseases
associated with ischemia and inflammation.
Action Pharma A/S,
Science Park Åarhus,
Brendstrupgårdsvej 102, 8200 Århus N,
Tel. + 45 4547 5000
www.actionpharma.com
2002
R&D,
Production
Produces lysine to the feedstuff industry utilizing residues from the
agro industry and agricultural plant products.
AgroFerm A/S,
Limfjordsvej 4, 6715 Esbjerg N,
Tel. +45 7915 9500
www.agroferm.dk
1960
R&D,
Production
Develops and produces products for diagnosis, prevention and
treatment of allergies.
ALK-Abelló A/S,
Bøge Alle 6-8, 2970 Hørsholm,
Tel. +45 4574 7445
www.alk-abello.com
A pharmaceutical development company engaged in development,
registration and commercialization of new generic OTC-products for
the pharmaceutical industry.
Alkalon ApS
Trojborggade 3A, 1757 Copenhagen
Tel. +45 8870 7768
www.alkalon.com
Produces active pharmaceutical ingredients (APIs) as well as
sterilized drugs.
Alpharma ApS,
Dalslandsgade 11, P.O. Box 1736,
2300 København S,
Tel +45 3264 5500
www.alpharma.dk
Focuses on supply of polyclonal antibodies
The Antibody Project ApS,
Kullingegade 31, 5700 Svendborg,
Tel. +45 2972 3157
www.antibodyproject.com
2007
1959
2006
Development
Production
R&D
Aresa A/S
Arpida A/S
Ascendis Pharma A/S
Astion Pharma A/S
Atonomics A/S
Baxter A/S
Bavarian Nordic A/S
Bifodan A/S
BioGasol ApS
Eftertryk er tilladt med tydelig angivelse af kilde
2001
2000
2007
2002
2000
R&D
Combines molecular biology and plant physiology with disciplines
like protein chemistry with focus on lancing plant-based solutions
and products.
Aresa A/S,
Symbion Science Park,
Fruebjergvej 3, 2100 København Ø,
Tel. +45 7022 7747
www.aresa.dk
R&D
Discovery and development of novel products for the treatment of
severe bacterial infections.
Arpida A/S,
Vesterbrogade 188, 1800 Frederiksberg C,
Tel. +45 7022 2365
www.arpida.com
R&D
Improving drugs by using a transient linker technology,
TransientLink, which conjugates peptides, proteins and small
molecules to a carrier molecule in a reversible fashion which allows
an unmodified active drug to be released in the body in a precise
fashion.
Ascendis Pharma A/S
Tuborg Boulevard 12, 2900 Hellerup
Tel. + 45 3694 4486
www.ascendispharma.com
R&D
Researches in safe and effective relief for patients suffering from
dermatological diseases with focus on development of antiinflammatory substances.
Astion Pharma A/S,
Fruebjergvej 3, 2100 Copenhagen,
Tel. +45 4333 4800
www.astion.com
R&D
Atonomics A/S,
Electro- and nano mechanical diagnostic Point of Care technologies. Vestre Teglgade 10, 2450 Copenhagen,
Develop biochip products.
Tel. +45 7027 1330
www.atonomics.com
Baxter A/S,
Gydevang 43, 3450 Allerod,
Tel. +45 4816 6400
www.baxter.dk
1983
Production
Produces pharmaceuticals and medico equipment used in the
treatment of patients with immunodeficiency, infectious diseases,
cancer, kidney diseases and trauma.
1994
R&D,
Production
Develops and produces innovative vaccines to prevent and treat
infectious diseases: smallpox, HIV and cancer.
Bavarian Nordic A/S,
Bøgeskovvej 9, 3490 Kvistgård,
Tel: +45 3326 8383
www.bavarian-nordic.com
1987
R&D,
Production
Develops and produces probiotic products and other preparations
for human and veterinary use. Bifodan is specialised in handling
lactic acid bacteria.
Bifodan A/S,
Bogbinderivej 6, 3390 Hundested,
Tel: +45 4798 1516
www.bifodan.dk
2006
R&D
BioGasol ApS
Develops and designs technologies needed for second generation
Technical University of Denmark, Building 205
bioethanol production. BioGasol´s process technology is innovative
2800 Lyngby
and offers a cost effective production of biofuels such as bioethanol,
Tel: +45 4045 9184
hydrogen, methane and other valuable byproducts.
www.biogasol.dk
Biogen Idec Manufacturing ApS
BioLocus A/S
Biomonitor ApS
BioPorto Diagnostics A/S
BKG Pharma ApS
Borean Pharma A/S
BSP Pharma A/S
Center for Clinical and Basic
Research A/S
Chr. Hansen A/S
Eftertryk er tilladt med tydelig angivelse af kilde
2001
R&D,
Production
Research and development within oncology, neurology and
immunology.
Biogen Idec Manufacturing ApS,
Biogen Idec Allé 1, 3400 Hillerød,
Tel.+ 45 7741 6000
www.biogenidec.dk
BioLocus A/S,
Agern Allé 3, 2970 Hørsholm ,
Tel +45 3555 0959
www.biolocus.com
Biomonitor ApS,
Fruebjergvej 3, 2100 Copenhagen Ø,
Tel. +45 3917 9705
www.biomon.dk
1999
R&D
Develops a technology that makes it possible to replace biocides in
anti-fouling paints for boats, ships and offshore constructions with
enzymes.
2003
R&D,
service
Develops clinically useful methods to monitor therapies with
cytokine-modulating biopharmaceuticals and to reveal and prevent
immunogenic properties of biopharmaceuticals.
2000
BioPorto develops and markets antibodies and antibody-based
Development, products, including tests to diagnose human disease. The
Company’s developments include a test (NGAL) to diagnose and
diagnostic
monitor acute kidney damage.
BioPorto Diagnostics A/S,
Grusbakken 8, 2820 Gentofte
Tel. +45 4529 0000
www.bioporto.com
R&D
Develops novel therapies against human pathogenic multiresistant
bacteria.
BKG-Pharma ApS,
Vintervej 2, 2920 Charlottenlund,
Tel.+45 3964 0742
www.bkgpharma.com /not active
R&D
A drug discovery and development company focused on
recombinant protein technology.
Borean Pharma A/S,
Gustav Wieds Vej 10, 8000 Aarhus C,
Tel. +45 8620 2000
www.boreanpharma.com
R&D
Focuses on relieving the symptoms of eczema, arthritis and muscle
pain, psoriasis and herpes simplex based on natural products.
BSP Pharma A/S,
M.P. Bruuns Gade 27, 8000 Aarhus C,
Tel. +45 8730 6293
www.bsp-pharma.com
1992
R&D
Basic and applied research in biology related to diseases in the
years after menopause, especially osteoporosis and other bonerelated diseases.
CCBR A/S,
Ballerup Byvej 222, 2750 Ballerup,
Tel. +45 4468 4600
www.ccbr.dk
1874
R&D,
Production
Develops natural ingredient solutions for the food, pharmaceutical,
nutritional and agricultural industries.
Chr. Hansen A/S,
Boege Alle 10-12, 2970 Hoersholm,
Tel. +45 4574 7474
www.chr-hansen.com
2004
1997
2001
CLC bio A/S
CMC Biopharmaceuticals A/S
Develops bioinformatic software based on the latest scientific
developments in bioinformatic.
CLC bio A/S,
Science Park Aarhus, Gustav Wieds Vej 10, 8000
Aarhus C,
Tel: +45 7022 3244
www.clcbio.com
Production
service
A Contract Manufacturing Organization offering manufacturing
services using microbial fermentation and mammalian cell culture
processes.
CMC Biopharmaceuticals A/S,
Vandtaarnsvej 83, 2860 Soeborg,
Tel. +45 7020 9470
www.cmcbio.com
Produces recombinant human intrinsic factor and recombinant
human transcobalamin to improve the diagnosis and treatment of
vitamin B12 deficiency.
2004
R&D
2001
Cobento Biotech A/S
2001
R&D,
Production
Colotech A/S
1999
R&D
Como Biotech ApS
Copenhagen Biotech
Assets ApS
2000
2002
Develops innovative drugs for the prevention and treatment of
human cancers and its precursors.
Cobento Biotech A/S,
Science Park Aarhus,
Gustav Wieds Vej 10, 8000 Aarhus C,
Tel. +45 8620 5095
www.cobento.com
Colotech A/S,
Copenhagen Science Park,
Fruebjergvej 3, 2100 Copenhagen,
Tel. +45 3917 9825
www.colotech.dk
R&D
Works with proteins for diagnostic/therapeutic purposes.
Como Biotech ApS,
c/o Østjysk Innovation A/S,
Gustav Wieds Vej 10, 8000 Århus C,
Tel: +45 8620 5190
R&D
Discovery within the area of protein misfolding, novel Bovine
Spongiforme Encephalopathies (BSE) diagnostic assays and novel
drugs against BSE and Alzheimer’s disease.
Copenhagen Biotech Assets ApS,
Caroline Mathilde Vej 11, 2950 Vedbæk,
Tel. +45 4586 3238
www.cbassets.com
Curalogic A/S
2004
R&D
Curalogic A/S,
Amagertorv 29A, 4th floor, 1160 Copenhagen K, Tel.
The primary therapeutic focus is the worldwide allergic rhinitis mark.
+45 3311 4101
www.curalogic.com
Cym1P A/S
2003
R&D
Enhanced production of recombinant peptides.
Eftertryk er tilladt med tydelig angivelse af kilde
Cym1P A/S,
Niels Jernes Vej 10, 9220 Aalborg Øst,
Tel. +45 96 35 45 00
CytoGuide ApS
Cytotech ApS
DanDrit Biotech A/S
Danisco A/S
2007
1989
R&D
Production
2001
R&D
1989
R&D,
Production
Develops two-component drugs which target specific receptors on
cells of the immune system, and by means of these receptors
ensure efficient uptake of the drug where it is needed. Main focus
area is inflammatory disease.
CytoGuide ApS
Gustav Wieds Vej 10, 8000 Århus C
Tel. +45 2899 2282
www.cytoguide.dk
Cytotech ApS,
Production of animal and normal human cell systems and related
Nordre Strandvej 119F, 3150 Hellebaek,
media for in vitro research, serum-free and customized media, sera,
Tel. +45 7023 6020
growth factors and supplements.
www.cytotech.dk
Develops cancer vaccines aimed at improving the patients’ immune
response against solid tumours and their metastases.
DanDrit Biotech A/S,
Symbion Science Park,
Fruebjergvej 3, Box 62, 2100 Copenhagen,
Tel.+45 3917 9840
www.dandrit.com
Produce ingredients for the food industry. The company’s broad
technology platform and product portfolio include emulsifiers,
enzymes, stabilisers, cultures, flavours, sugar and sweeteners.
Danisco A/S,
Langebrogade 1, 1001 Copenhagen,
Tel.+45 3266 2000
www.danisco.dk
Research and development of drug delivery device technology, and
novel therapeutic approaches involving pulmonary and nasal
delivery.
Direct-Haler A/S,
Symbion Science Park,
Fruebjergvej 3, 2100 Copenhagen,
Tel.+45 3917 9696
www.direct-haler.com
DNA Technology A/S,
Science Park Aarhus,
Gustav Wieds Vej 10A, 8000 Aarhus C,
Tel. +45 8732 3000
www.dna-technology.dk
Direct-Haler A/S
1994
R&D
DNA Technology A/S
1992
R&D, R&D
service
Manufactures customer defined oligonucleotides. Research and
development is focused on a product line comprised by molecular
human diagnostic systems.
Development
Files use-patents on well known already approved and marketed
drugs in new indications for treatment of critical ill patients. The
company’s highest priority is the Granulocyte Macrophage Colony
Stimulationg Factor (GM-CSF) project
Drugrecure ApS
Agern alle 3, Scion-DTU, 2970 Hørsholm
Tel. +45 4358 3759
www.drugrecure.com
Focus on the formulation and development of controlled release
products.
Egalet A/S,
Lejrvej 37-41, 3500 Vaerløse,
Tel.+45 4447 8080
www.egalet.com
Produces blood type determining cards.
Eldon Biologicals A/S,
Sandtoften 10, 2820 Gentofte,
Tel.+45 4593 1111
www.eldoncard.com
Drugrecure ApS
Egalet A/S
Eldon Biologicals A/S
Eftertryk er tilladt med tydelig angivelse af kilde
2007
1987
R&D
1993
R&D,
Production
Enfutech ApS
2007
Development
Using Retrovec’s license for development of potential treatment of
HIV patients
Enfutech ApS
Gustav Wieds Vej 10, 8000 Århus C
Tel. +45 8620 5188
ENKAM Pharmaceuticals A/S,
Fruebjergvej 3, Box 58, 2100 Copenhagen Ø,
Tel.+45 3917 9715
www.enkam.com
ENKAM Pharmaceuticals A/S
2000
R&D
Works within the field of neural cell adhesion molecules and has a
focus on neurodegenerative disorders and cancer.
Entrop Pharma A/S
2007
R&D
Development of pharmaceuticals against inflammation.
Entrop Pharma A/S
Østergade 5, 3
1100 København K
Uses genetic engineering to evolve small molecule drugs.
Evolva Biotech A/S,
Bülowsvej 25, 1870, Frederiksberg C,
Tel.+45 3536 4429
www.evolvabio.com
Evolva Biotech A/S
Exiqon A/S
FCMB ApS
Ferring Pharmaceuticals A/S
Fertin Pharma A/S
Fisher BioImage A/S
Eftertryk er tilladt med tydelig angivelse af kilde
2001
R&D
1996
R&D,
Production
2005
R&D
1992
R&D,
Production
2001
R&D,
Production
1998
R&D service
Exiqon A/S,
Develops immuno- and molecular genetic-diagnostics, based on
Bygstubben 9, 2950 Vedbaek,
immobilization of biomolecules to surfaces and locked nucleic acids. Tel. +45 4566 0888
www.exiqon.com
Develops and commercialises a novel platform that can be used for
non-invasive prenatal diagnostics.
FCMB ApS,
Tysklandsvej 7, 7100 Vejle
Tel. +45 3693 8850
www.fcmb.dk
Develops products in the fields of urology, gynaecology and
obstetrics, gastroenterology and endocrinology.
Ferring Pharmaceuticals A/S,
Kay Fiskers Plads 11, 2300 Copenhagen S,
Tel. +45 8816 8817
www.ferring.com
Develops medical chewing gum.
Fertin Pharma A/S,
Industrivej 8, 7120 Vejle,
Tel. +45 7215 1300
www.fertin.com
Develops proprietary assays for the monitoring of protein
translocations in living cells. These assays are sold to
biopharmaceutical companies that are engaged in drug discovery.
BioImage A/S,
Moerkhoej Bygade 28, 2860 Soeborg,
Tel. +45 3954 0800
www.bioimage.com
Fluxome Sciences A/S
Forward Pharma A/S
Gastrotech Pharma A/S
2002
2005
2003
R&D
Develops innovative and cost-effective bioprocesses by employing
metabolic engineering.
Fluxome Sciences A/S,
Diplomvej 378, 2800 Kgs. Lyngby,
Tel.+45 8870 8400
www.fluxome.com
R&D
Develops immunomodulatory drugs for the treatment of a range of
common disorders. Main focus is dermatology.
Forward Pharma A/S,
Østergade 5, 3, 1100 Copenhagen K,
Tel: +45 2427 6653
www.forward-pharma.com
Develops therapeutics based on gastrointestinal peptide hormones.
Gastrotech Pharma A/S,
Nyhavn 43B, 1051 Copenhagen K,
Tel. +45 3344 4242
www.gastrotechpharma.com
R&D
Genmab A/S
1999
R&D
Develops human antibodies for the treatment of cancer, infectious
disease, rheumatoid arthritis and other inflammatory conditions.
Genmab A/S,
Toldbodgade 33, P.O. Box 9068,
1253 Copenhagen K,
Tel.+45 7020 2728
www.genmab.com
Genobiotix ApS
2004
R&D
Develops new antibiotics against multi-resistant bacteria.
Genobiotix ApS,
Forskerparken 10, 5230 Odense
www.genobiotix.com / not active
Develops a production technology based on cultivation of medicinal
mushrooms in submerged culture. The method can be utilised to
manufacture a number of different immune stimulating agents.
GlycaNova A/S,
Innovation Centre,
Agern Allé 3, 2970 Hørsholm,
Tel +45 4698 7140
www.medimush.dk
Engaged in the preparation of novel biomolecules for the
pharmaceutical and food industries. Applies multifunctional
molecular engineering and advanced peptide and protein
engineering.
Glycom ApS,
Diplomvej 373, 2800 Kgs. Lyngby,
Tel. +45 4525 6781
www.glycom.dk
Develops new drugs for treatment of CNS disorders, including
depression, schizophrenia, Alzheimer’s disease and Parkinson’s
disease.
H. Lundbeck A/S,
Ottiliavej 9, 2500 Valby,
Tel. +45 3630 1311
www.lundbeck.com
Pioneering cognitive technologies designed to help and empower
people. They create tiny implants that monitor brain activity to
convey relevant information and issue alerts, and are currently
clinically testing the world’s first EEG monitoring device for diabetics
unable to feel and respond to a critical low blood sugar level.
Hypo-Safe A/S,
Diplomvej 381, 2800 Kgs. Lyngby
Tel. +45 2148 3588
www.hyposafe.com
GlycaNova A/S
Glycom ApS
H. Lundbeck A/S
Hypo-Safe
Eftertryk er tilladt med tydelig angivelse af kilde
2002
R&D,
Production
2005
R&D
1915
R&D,
Production
2005
R&D
Ilochip A/S
Inagen A/S
Interface Biotech A/S
LEO Pharma A/S
LICA Pharmaceuticals A/S
LifeCycle Pharma A/S
LiPlasome Pharma A/S
Maxygen ApS
MediCult A/S
Eftertryk er tilladt med tydelig angivelse af kilde
R&D
Develops a micro-device, which provide remote, reliable and rapid
detection of biological warfare agents.
Ilochip A/S,
Stroemmen 6, 9400 Noerresundby,
Tel. +45 9811 5650
www.ilochip.com
R&D
Development of drugs against virus infections, especially
Cytomegalovirus. The drugs consist of toxins bound to signal
molecules specifically taken into virus infected cells.
Inagen Aps
c/o Risøe National Laboratory
Frederiksborgvej 399, Building 330, 4000 Roskilde
www.inagen.com
1998
R&D
An orthopaedic oriented biotech company specialized in culturing
human cells for cartilage and bone repair.
Interface Biotech A/S,
Venlighedsvej 6, 2970 Hørsholm,
Tel. +45 4698 5220
www.aci.dk
1908
R&D,
Production
Researches and develops small molecule drug candidates within
the fields of dermatology, cardiovascular diseases, antithrombotics,
antibiotics, and bone metabolism.
LEO Pharma A/S,
Industriparken 55, 2750 Ballerup,
Tel. +45 4494 5888
www.leo-pharma.com
2001
2007
2000
2002
R&D
LICA Pharmaceuticals A/S,
Develops novel compounds for the treatment of bacterial and
Symbion Science Park,
parasitic diseases such as hospital-acquired infections, gastric ulcer Fruebjergvej 3, 2100 Copenhagen,
and malaria.
Tel. +45 3917 9796
www.licapharma.com
R&D
LifeCycle Pharma A/S,
Develops a drug delivery technology platform for dramatically
Kogle Allé 4, 2970 Hørsholm,
enhancing the bioavailability of compounds with low water-solubility. Tel.+ 45 7033 3300
www.lcpharma.com
R&D
Develops novel prodrug and drug delivery systems based on
nanocarriers for targeted delivery of anticancer drugs.
LiPlasome Pharma A/S,
Technical University of Denmark,
Building 207, 2800 Lyngby,
Tel.+45 4525 2458
www.liplasome.com
1999
R&D
Develops protein based pharmaceuticals through structure-based
analysis and robotic screening of candidate molecules.
Maxygen ApS,
Agern Allé 1, 2970 Hørsholm,
Tel. +45 7020 5550
www.maxygen.dk
1987
R&D,
Production
Develops new and existing techniques within fertility treatment.
MediCult A/S,
Møllehaven 12, 4040 Jyllinge,
Tel. +45 4679 0200
www.medicult.com
2001
Microlytic ApS
Molegro ApS
MycoTeQ A/S
NatImmune A/S
Neurokey A/S
NeuroSearch A/S
Nordic Bioscience A/S
Nordic Vaccine A/S
Nota Bene Scientific Aps
Eftertryk er tilladt med tydelig angivelse af kilde
develops microfluidic technology to speed up the structure
determination pipeline for crystallographers.
Microlytic ApS,
Universitetsparken 7, 4000 Roskilde,
Tel. +45 4674 0200
www.microlytic.com
Develops high-performance drug discovery software solutions
leading to a faster drug-development process.
Molegro ApS,
Høegh-Guldbergs Gade 10,
Building 090, 8000 Aarhus C,
Tel. +45 8942 3165
www.molegro.com
R&D
Focuses on microfungi.
MycoTeQ A/S,
Søltofts Plads 221, 2800 Kgs. Lyngby,
Tel. +45 2861 6845
www.mycoteq.com
R&D
Develops protein-based therapeutics for the prevention and
treatment of infectious diseases and inflammation.
NatImmune A/S,
Fruebjergvej 3, box 3, 2100 Copenhagen Ø,
Tel. +45 7022 3560
www.natimmune.dk
R&D
Neurokey A/S
Develops drugs for the critical care segment. Neurokey products are Diplomvej 381, 2800 Lyngby
based on both original ideas and in-licensing.
Tel. +45 3020 5895
www.neurokey.dk
1988
R&D
NeuroSearch A/S,
Diseases in the Central Nervous System and other diseases treated
Pederstrupvej 93, 2750 Ballerup,
primarily through ion channel modulation, including compounds for
Tel.+45 4460 8000
the treatment of ADHD, cancer, epilepsy, and Parkinson's disease.
www.neurosearch.com
1998
R&D,
Production
2006
2005
2006
2000
2007
2001
1990
R&D
R&D
R&D
Production
Develops therapeutic compounds and diagnostic products for
diseases affecting bone and cartilage, such as osteoporosis,
osteoarthritis and bone metastasis.
Nordic Bioscience A/S,
Herlev Hovedgade 207, 2730 Herlev,
Tel.+45 4454 7777
www.nbdiagnostics.com
Nordic Vaccine A/S,
Develops vaccines for prophylactic as well as therapeutic use.
Symbion Science Park,
Focused on vaccines for infectious diseases, DNA-delivery
Fruebjergvej 3, 2100 Copenhagen Ø,
technologies for use in therapeutic DNA-vaccines and gene therapy.
Tel.+45 4033 9266
Produces antibodies and other immunology reagents.
Nota Bene Scientific ApS,
Nordre Strandvej 119F, 3150 Hellebaek,
Tel.+45 7023 2060
www.nbs.dk
1923
R&D,
Production
Focuses on diabetes treatment and insulin delivery systems. The
company is also involved within areas such as haemostasis
management, growth hormone therapy and hormone replacement
therapy.
Novo Nordisk A/S,
Novo Allé, 2880 Bagsværd,
Tel. +45 4444 8888
www.novonordisk.com
Novozymes A/S
1941
R&D,
Production
Focused on microbiology, biotechnology and gene technology.
Develop and refine enzymes and microorganisms to improve
industrial performance.
Novozymes A/S,
Krogshoejvej 36, 2880 Bagsvaerd,
Tel: +45 8824 9999
www.novozymes.com
NSexplorer A/S
2002
R&D
Focuses on new mechanisms for the treatment of tension type
headache.
NSexplorer A/S,
Pederstrupvej 93, 2750 Ballerup,
Tel.+45 4460 8000
R&D
Develops novel cell and gene based products for the treatment of
neurological diseases such as Alzheimer's disease, Parkinson's
disease, epilepsy, and neuropathic pain.
NsGene A/S,
Baltorpvej 154, 2750 Ballerup,
Tel. +45 4460 8900
www.nsgene.dk
R&D
Nuevolution A/S,
Develops a unique drug discovery technology that enables the rapid
Rønnegade 8, 2100 Copenhagen,
synthesis and screening of many billions of drug-like molecules in a
Tel. +45 7020 0987
single test tube.
www.nuevolution.com
R&D
Develops products for cancer treatment and a new drug delivery
system.
Oncotac Pharmaceuticals ApS,
Symbion Science Park,
Fruebjergvej 3, 2100 Copenhagen Ø
www.oncotac.com / not active
Develops pharmaceutical products for bone and cartilage disorders.
Osteologix A/S,
Symbion Science Park,
Fruebjergvej 3, box 4,2100 Copenhagen Ø,
Tel. + 45 3917 9730
www.osteologix.com
Real time PCR technology
Pentabase ApS,
Sunekaer 1, 5471 Soendersoe,
Tel. +45 6388 2047
www.pentabase.com
Develops products for wound treatment.
Pharma 2100 A/S,
Symbion Science Park,
Fruebjergvej 3, 2100 Copenhagen Ø
Novo Nordisk A/S
NsGene A/S
Nuevolution A/S
Oncotac Pharmaceuticals ApS
Osteologix A/S
1999
2001
2002
2003
R&D
Pentabase ApS
2006
R&D,
Production
Pharma 2100 ApS
2004
R&D
Eftertryk er tilladt med tydelig angivelse af kilde
Pharmacosmos A/S
Pharmaorigin ApS
1965
2007
R&D,
Production
Development
Pharmacosmos A/S,
Manufactures and develops intravenous iron infusion and iron
Rørvangsvej 30, 4300 Holbæk,
injection compounds and Dextran carbohydrate polymers, which are
Tel.+45 5948 5959
essential in the treatment of anaemia in humans.
www.pharmacosmos.com
Files use-patents on well known already approved and marketed
drugs in new indications for treatment of critical ill patients. The
company focuses on Factor VIIa to treat diffuse alveolar
hemorrhage.
Pharmaorigin ApS
Agern alle 3, Scion-DTU, 2970 Hørsholm
Tel. +45 4358 3759
www.pharmaorigin.com
Pharmexa A/S
1990
R&D
Pharmexa A/S,
Develops new immunotherapy drugs for the treatment of cancer and Kogle Allé 6, 2970 Hoersholm,
inflammatory diseases.
Tel.+45 4516 2525
www.pharmexa.com
Pharmos Bioscience A/S
2004
R&D
Focused on bone diseases.
Pharmos Bioscience A/S,
Ballerup Byvej 222, 2750 Ballerup,
Tel.+45 44525252
A pharmacological contract research organisation with the capacity
to combine advanced molecular biology with pre-clinical research,
aimed at drug discovery and early drug development.
Pipeline Biotech A/S,
Roevedvej 1, 8380 Trige,
Tel. +45 7022 0840
www.pipeline-biotech.dk
Manufactures Dextran derivatives and other carbohydrate-based
chemicals.
PK Chemicals A/S,
Koebenhavnsvej 140, 4600 Koege,
Tel.+45 5663 0300
www.pkcas.dk
Pipeline Biotech A/S
1999
R&D service
PK Chemicals A/S
1991
Production
Poalis A/S
2001
R&D
Develop biological production processes for aromas and other high
value chemicals.
Poalis A/S,
Kirkeleddet 125, 3480 Fredensborg,
Tel.+45 3339 4212
Poseidon Pharmaceuticals A/S
2001
R&D
Research and development is aimed at new therapies for diseases
outside the CNS area.
Poseidon Pharmaceuticals A/S,
Pederstrupvej 93, 2750 Ballerup,
Tel.+45 4460 8000
Develops non-invasive and accurate glucose reading products.
PreciSense A/S,
Dr. Neergaards Vej 3, 2970 Hørsholm,
Tel.+45 4517 9500
www.precisense.dk
PreciSense A/S
Eftertryk er tilladt med tydelig angivelse af kilde
1995
R&D
ProteoTarget ApS
2002
R&D
Develops a novel phage display technology platform to accelerate
drug discovery and to allow targeting of intracellular proteins.
Prozymex Pharmaceuticals A/S
1999
R&D
Researches in DPPI and DPPI inhibitors for disease treatment.
ProteoTarget ApS,
Tranbjerg Stationsvej 1, 8310 Tranbjerg J,
Tel.: +45 8672 2055
www.proteotarget.dk
ProZymex Pharmaceuticals A/S,
Dr. Neergaards Vej 17, 2970 Hørsholm,
Tel.+45 4576 0154
QSI Pharma A/S
2002
R&D
QSI Pharma A/S,
Researches in Quorum Sensing Inhibitors. Treatment to reduce the
Søltofts Plads, 2800 Kongens Lyngby,
risk of developing resistant bacteria strains in patients enrolled in
Tel.+45 4525 2600
long-term treatment with antibiotics.
www.qsi-pharma.com
Quantibact A/S
2004
R&D
New method for measuring the number and the sort of bacteria in
urine.
Quantibact A/S,
Kettegårs Allé, 2650 Hvidovre
R&D
Develops therapeutical anti-malaria antibodies with the potential to
eliminate the malaria parasite at the merezoite stage.
Ram Biotech ApS,
Rigshospitalet,
Blegdamsvej 9, 2100 Copenhagen Ø,
Tel.+45 3545 2036
R&D
ReceptIcon ApS,
Focuses on discovery of receptors in the kidney that are responsible
Gustav Wieds Vej 10, 8000 Aarhus C,
for renal uptake and nephrotoxicity of some of the most commonly
Tel: +45 8620 5190
used therapeutics worldwide.
www.recepticon.com
RAM Biotech ApS
ReceptIcon ApS
RetroVec ApS
Rheoscience A/S
RiboTask ApS
Eftertryk er tilladt med tydelig angivelse af kilde
2003
2001
Develops retroviral gene transfer technology.
RetroVec ApS c/o Østjysk Innovation A/S, Gustav
Wieds Vej 10, DK 8000 Århus C,
Tel. +45 8620 5190
www.retrovec.dk
R&D, R&D
service
Researches within the fields of diabetes and obesity. Provides preclinical contract research and clinical development consultancy.
Rheoscience A/S,
Glerupvej 2, 2610 Roedovre,
Tel. +45 4450 1960
www.rheoscience.com
R&D, Service
Offers RNA- and LNA-based products to companies within
biotechnology and to academic research laboratories. The products
down regulate disease-promoting genes and hereby stop the
development of the sick cells.
RiboTask ApS
Sdr. Boulevard 44, 3. sal, 5000 Odense C,
Tel. +45 4097 3682
www.ribotask.com
2004
R&D
2002
2006
Sanos Bioscience A/S
Santaris Pharma A/S
Schafer-N ApS
SD Genomics A/S
2003
2003
1995
2006
R&D
Focuses on diseases involving skeletal wasting such as
osteoporosis.
Sanos Bioscience A/S,
Glerupvej 2, 2610 Roedovre,
Tel.+45 4424 1024
www.sanosbioscience.com
R&D
Develops cancer treatments using high affinity LNA antisense
chemistry.
Santaris Pharma A/S,
Bøge Allé 3, 2970 Horrsholm,
Tel. +45 4517 9800
www.santaris.com
Synthesizes custom defined peptides.
Schafer-N ApS,
Lersø Park Allé 42, 2100 Copenhagen,
Tel. +45 3927 3800
www.schafer-n.com
Specializes in providing biotechnological products and services
including oligonucleotides, sequencing services, bioinformatics
services, and microarrays.
SD Genomics A/S,
Science Park Aarhus,
Gustav Wieds Vej 10, 8000 Aarhus C,
Tel. +45 8620 5230
www.sdgenomics.dk
Development of products in both the anti-aging and sexual
dysfunction categories.
Senetek Denmark ApS,
Gustav Wieds Vej 10,
8000 Aarhus C
www.senetekplc.com
Production
Service
Senetek Denmark ApS
2005
R&D
SKAUvaccine ApS
2007
Development
1986
R&D,
Production
2000
R&D,
Production
Soilrem A/S
Sophion Bioscience A/S
Spree Pharma A/S
Eftertryk er tilladt med tydelig angivelse af kilde
2007
Development
SKAUvaccine ApS
Using Retrovec’s license for development of a potential HIV vaccine Gustav Wieds Vej 10, 8000 Århus C
Tel. +45 8620 5188
Biotechnological cleaning of contaminated soil by bioremediation,
electro dialysis and organic solvents.
Bioteknisk Jordrens Soilrem A/S,
Maglehøjvej 10, 4400 Kalundborg,
Tel.+45 5950 4668
www.soilrem.dk
Microchip-based automated patch clamp systems.
Sophion Bioscience A/S,
Baltorpvej 154, 2750 Ballerup,
Tel. +45 4460 8800
www.sophion.dk
Spree Pharma uses iCeutica’s proprietary Encapsulated Organic
Nanoparticle Platform to reformulate a number of compounds for
launch and marketing in focused therapeutic indications.
Spree Pharma A/S
Østergade 5, 3
1100 København K
Statens Serum Institut
1902
R&D,
Production
Stevia ApS
2001
R&D
Symphogen A/S
2000
R&D
TAG Copenhagen A/S
1996
R&D,
Production
TopoTarget A/S
2000
R&D
1989
R&D, R&D
service
Unizyme Laboratories A/S
Valderm ApS
VersaMatrix A/S
Vipergen ApS
Eftertryk er tilladt med tydelig angivelse af kilde
2003
R&D
2002
R&D,
Production
2005
R&D
Prevents and controls infectious diseases, biological threats, and
congenital disorders.
Statens Serum Institut,
Artillerivej 5, 2300 Copenhagen S,
Tel.+45 3268 3268
www.ssi.dk
Develops a pharmaceutical therapy for diabetes type 2 and the
metabolic syndrome, based on molecular structures found in the
plant stevia rebaudiana.
Stevia ApS,
Sponnecksvej 4, 2820 Gentofte,
Tel.+45 4128 5556
Develop recombinant human polyclonal antibodies.
Symphogen A/S,
Elektrovej Building 375, 2800 Lyngby,
Tel. +45 4526 5050
www.symphogen.com
Develops instruments and software for DNA and peptide synthesis.
Develops cancer treatment drugs which target key molecular
mechanisms associated with the cell cycle, chromatin control and
DNA damage.
TAG Copenhagen A/S,
Research Park Symbion,
Fruebjergvej 3, 2100 Copenhagen O,
Tel.+45 3917 9707
www.tagc.com
TopoTarget A/S,
Symbion Science Park,
Fruebjergvej 3, 2100 København Ø,
Tel. +45 3917 8392
www.topotarget.com
Develops proteins with main focus on peptidases for use in
downstream processing, peptide synthesis and drug discovery.
Unizyme Laboratories A/S,
Dr. Neergaardsvej 17, 2970 Hoersholm,
Tel.+45 45760154
www.unizyme.com
A development company focusing on pharmaceutical development
of anthracyclines into topical formulations for treatment of
hyperproliferative skin diseases.
Valderm ApS,
Lundtoftevej 277, 2800 Kgs. Lyngby,
Tel: + 45 2221 6018
www.valderm.dk
VersaMatrix A/S,
Develops a technology for the fast identification and development of Gamle Carlsberg Vej 10, 2500 Valby,
affinity ligands.
Tel. +45 3327 5320
www.versamatrix.com / not active
Develops a drug discovery technology platform providing access to
small molecule combinatorial libraries of up to 1012 compounds.
Vipergen ApS,
Fruebjergvej 3, 2100 Copenhagen,
Tel. +45 3917 9798
www.vipergen.com
ViroGates A/S
Zealand Pharma A/S
ZGene A/S
Zymenex A/S
2CureX ApS
7 TM Pharma A/S
Eftertryk er tilladt med tydelig angivelse af kilde
2000
1998
2001
1998
2006
2000
Focused on HIV research and disease prognostics.
ViroGates A/S,
Scion-DTU, Diplomvej 377, 2800 Lyngby,
Tel. +45 8870 8258
www.virogates.com
R&D
Develops peptide-based drugs that target diseases and symptoms.
Zealand Pharma A/S,
Smedeland 26 B, 2600 Glostrup,
Tel. +45 4328 1200
www.zp.dk
R&D
Focused on improving existing cancer treatments. Develops a
technology that enhances the effect of current anti-cancer drugs
and reduces their toxicity.
ZGene A/S,
Agern Allé 7, 2970 Hoersholm,
Tel.+45 8888 7676
www.zgene.net
R&D
Develops innovative therapeutics for life threatening diseases such
as lysosomal storage diseases.
Zymenex A/S,
Roskildevej 12 C, 3400 Hillerød,
Tel. +45 4825 0054
www.zymenex.com
R&D
Develops drug candidates for the treatment of cancer with focus on
colon and neuronal cancer.
2CureX ApS
Birkevej 37, 3460 Birkerød
Tel. +45 2211 5399
www.2curex.com
R&D
Develops novel drugs for 7TM receptor targets with therapeutic
focus on metabolic disorders, including obesity, and inflammatory
disorders, targeting allergic rhinitis and asthma.
7TM Pharma A/S,
Fremtidsvej 3, 2970 Hoersholm,
Tel. +45 3925 7777
www.7tm.com
R&D